Work with us
Partnerships that power new rare disease treatments
True medical breakthroughs happen when industry, patient groups and academic institutions work together. Let’s collaborate to accelerate the development of novel treatments for rare diseases
Whilst cutting-edge AI technology is integral to our work, we couldn’t have achieved as much as we have done to date without the involvement of our partners. We welcome enquiries from groups interested in partnering with us to progress treatments for rare diseases.
Biotech and pharma
Ways of working together
The Rare Treatment Accelerator
Our Rare Treatment Accelerator partnering programme connects research institutions, patient organisations and early-stage biotechs. Working together we can quickly turn your research, insights and promising repurposing therapies into novel treatments that will benefit rare disease patients.
We work across a range of rare disease areas and have a number of treatments progressing towards the clinic. We welcome enquiries both from groups whose diseases of interest fit with our current portfolio, along with those from groups working on other rare conditions where relevant assets, resources and data are available.